Foldax

Salt Lake City, United States

Foldax is engages in synthetic heart valve development to deliver non-thrombogenic aortic and mitral valves at dramatically lower cost.

$7.0M raised

Nov 2023

Venture - Series Unknown

Top Investors

CaltechKairos VenturesBioStar CapitalMemorialCare Innovation FundAngel Physicians Fund

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Foldax raised?

Foldax has raised $7.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2023.

Who are Foldax's investors?

Foldax's investors include Caltech, Kairos Ventures, BioStar Capital, MemorialCare Innovation Fund, Angel Physicians Fund.

Where is Foldax headquartered?

Foldax is headquartered in Salt Lake City, United States.

What does Foldax do?

Foldax is engages in synthetic heart valve development to deliver non-thrombogenic aortic and mitral valves at dramatically lower cost.

What stage is Foldax at?

Foldax is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 7, 2023.

MLA

"Foldax — Funding & Investors." VCBacked, November 7, 2023, https://www.vcbacked.co/company/foldax. Accessed June 13, 2026.

APA

VCBacked. (2023). Foldax — Funding & Investors. Retrieved June 13, 2026, from https://www.vcbacked.co/company/foldax

Wikipedia (cite web)

{{cite web |title=Foldax — Funding & Investors |url=https://www.vcbacked.co/company/foldax |website=VCBacked |access-date=June 13, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 7, 2023.